| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.0075 | 1 |